Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Inappropriate schedule of product administration, Maternal exposure during pregnancy, Pyrexia
Clinical narrative: had a fever; Stayed in bed; Pregnancy; Inappropriate schedule of vaccine administered; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PYREXIA (had a fever), BEDRIDDEN (Stayed in bed), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder. Concomitant products included METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) for Drug therapy.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 19-Nov-2021. On 20-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 28-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). On an unknown date, the patient experienced PYREXIA (had a fever) and BEDRIDDEN (Stayed in bed). On 28-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. At the time of the report, PYREXIA (had a fever) and BEDRIDDEN (Stayed in bed) outcome was unknown.            Concomitant medication includes-Thyroid medication No treatment medication was provided  This case of inappropriate schedule of vaccine administration and maternal exposure during pregnancy, first trimester, concerns a 38-year-old female patient with relevant medical history of thyroid disorder and concurrent use of methylprednisolone for fertility therapy,  who experienced associated non serious expected events of bedridden and expected event of pyrexia. The events occurred after the second dose of Spikevax however, the exact time to onset and onset date were not provided. Rechallenge was not applicable since the events occurred after the second dose. Patient's thyroid disorder and concurrent use of methylprednisolone are possible confounders. The benefit-risk relationship of drug is not affected by this report; Sender's Comments: This case of inappropriate schedule of vaccine administration and maternal exposure during pregnancy, first trimester, concerns a 38-year-old female patient with relevant medical history of thyroid disorder and concurrent use of methylprednisolone for fertility therapy,  who experienced associated non serious expected events of bedridden and expected event of pyrexia. The events occurred after the second dose of Spikevax however, the exact time to onset and onset date were not provided. Rechallenge was not applicable since the events occurred after the second dose. Patient's thyroid disorder and concurrent use of methylprednisolone are possible confounders. The benefit-risk relationship of drug is not affected by this report